Ozempic Company - Search News

Ozempic, chronic kidney disease

BioPharma Dive · 14h

FDA clears use of Ozempic to protect kidney health

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.

Ozempic approved for chronic kidney disease patients

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy

The New York Times · 1d

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

1don MSN

Skinny ‘Ozempic’ phones are making a comeback: ‘A nostalgic twist’

Smartphones are taking a shot at slenderizing in a nod to Ben Stiller’s itty-bitty mobile in the early-aughts classic ...

3d

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results